Brooks Laboratories Ltd BROOKS-IN:National Stock Exchange of India

*Data is delayed | INR
Last | 4:48 PM IST
60.00quote price arrow down-0.30 (-0.50%)
Volume
23,469
52 week range
13.85 - 77.75

...

Loading . . .

KEY STATS

  • Open59.00
  • Day High62.40
  • Day Low57.30
  • Prev Close60.30
  • 52 Week High77.75
  • 52 Week High Date01/08/21
  • 52 Week Low13.85
  • 52 Week Low Date03/27/20
  • Market Cap21.19M
  • Shares Out24.7M
  • 10 Day Average Volume55,712
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change144.9

RATIOS/PROFITABILITY

  • EPS (TTM)-3.70
  • P/E (TTM)-16.22
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Brooks Laboratories Ltd News

There is no recent news for this security.

Latest BROOKS-IN News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Brooks Laboratories Limited is a pharmaceutical manufacturing company. The Company is engaged in manufacturing of drugs and pharmaceuticals. The Company is a contract manufacturing company for molecules in Injectables and Clavulanic Acid range in tablets and dry syrups. The Company has a range of products catering to critical care segment in parental section, such as Beta Lactam, Cephalosporin and General dry powder Injectables, Ampoules and Liquid vials. Its products include...
Atul Ranchal
Chairman
Durga Maity
Chief Executive Officer
Anil Pillai
Chief Financial Officer
Address
502 Andheri, Andheri Kurla Road
Mumbai
400093
India